Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?

Diseases of the Esophagus

Volumn 20, Issue 1, 2007, Pages 36-41

  Chandrasoma, P ^a,b   Wickramasinghe, K ^a   Ma, Y ^a   Demeester, T ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Barrett's esophagus; Gastric cardia; Intestinal metaplasia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CARDIA; COLUMNAR EPITHELIUM; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; FEMALE; GASTRECTOMY; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; MALE; PRECANCER; PREVALENCE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH MUCOSA; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARDIA; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRECTOMY; GOBLET CELLS; HUMANS; INTESTINAL MUCOSA; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 33846230438     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00638.x     Document Type: Article

References (27)

1. Paull A, Trier J S, Dalton M D, Camp R C, Loeb P, Goyal R K. The histologic spectrum of Barrett's esophagus. N Eng J Med 1976; 295: 476-80.
2. Chandrasoma P T, Lokuhetty D M, DeMeester T R et al. Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol 2000; 24: 344-51.
3. Chandrasoma P. Controversies of the cardiac mucosa and Barrett's esophagus. Histopathol 2005; 46: 361-73.
4. Hawe A, Payne W S, Weiland L H. Adenocarcinoma in the columnar epithelial lined lower (Barrett's) esophagus. Thorax 1973; 28: 511-4.
5. Haggitt R C, Tryzelaar J, Ellis F H et al. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 1978; 70: 1-5.
6. Haggitt R C, Dean P J. Adenocarcinoma in Barrett's epithelium. In: Spechler S J, Goyal R K, (eds). Barrett's Esophagus: Pathophysiology, Diagnosis and Management. New York: Elsevier Science Publishing, 1985, 153-166.
7. Reid B J, Weinstein W M. Barrett's esophagus and esophageal adenocarcinoma. Annu Rev Med 1987; 38: 477-92.
8. Hayward J. The lower end of the oesophagus. Thorax 1961; 16: 36-41.
9. Spechler S J, Zeroogian J M, Antonioli D A, Wang H H, Goyal R K. Prevalence of metaplasia at the gastroesophageal junction. Lancet 1994; 344: 1533-6.
10. Sampliner R E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 1998; 93: 1028-31.
11. Spechler S J. The columnar lined esophagus: History, terminology, and clinical issues. Gastroenterol Clin N Am 1997; 26: 455-66.
12. Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and management of Barrett's esophagus: The AGA Chaicago Workshop. Gastroenterology 2004; 127: 310-30.
13. Blot W J, Devesa S S, Kneller R W, Fraumeni J F Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
14. Blot W J, Devesa S S, Fraumeni J F. Continued climb in rates of esophageal adenocarcinoma; an update. JAMA 1993; 270: 1320.
15. Devesa S S, Blot W J, Fraumeni J F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
16. Spechler S J. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 1999; 117: 218-28.
17. Hirota W K, Loughney T M, Lazas D J, Maydonovitch C L, Rholl V, Wong R K H. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data. Gastroenterology 1999; 116: 277-85.
18. Rex D K, Cummings O W, Shaw M et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003; 125: 1670-7.
19. Association of Directors of Anatomic and Surgical Pathology. Recommendations for reporting of resected esophageal adenocarcinomas. Am J Surg Pathol 2000; 31: 1188-90.
20. Chandrasoma P. Non-neoplastic diseases of the esophagus. In: Chandrasoma P, (ed.) Gastrointestinal Pathology. Appleton & Lange: Stamford, CT, 1999; 9-36.
21. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
22. Hamilton S R, Smith R R L, Cameron J L. Prevalence and characteristics of Barrett's esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988; 19: 942-8.
23. Cameron A J, Souto E O, Smyrk T C. Small adenocarcinomas of the esophagogastric junction: Association with intestinal metaplasia and dysplasia. Am J Gastroenterol 2002; 97: 1375-80.
24. van Sandick J W, van Lanschot J J, ten Kate F J et al. Pathology of early invasive adenocarcinoma of the esophagus and esophagogastric junction: Implications for therapeutic decision making. Cancer 2000; 88: 2429-37.
25. Odze R D. Unraveling the mystery of the gastroesophageal junction: A pathologist's perspective. Am J Gastroenterol 2005; 100: 1853-67.
26. Ruol A, Parent A, Zaninotto G et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett's esophagus and adenocarcinoma of the gastric cardia. Cancer 2000; 88: 2520-8.
27. Parsonnett J, Friedman G D, Vandersteen D P et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.